Tracker

ETF universe handoff

Opening ETF evidence benchSynchronizing prices, risk metrics, holdings coverage, and source lineage

Company context

FUJIFILM Holdings Corp

TSE:4901

Medical Specialties · benchmarked against Health Technology inside the JPJY constituent company universe.

Active tabFinancial reports

Current readMixed

Last close3,653.00

1M return+0.86%

Open symbol page Watchlist context

OverviewVerdict, thesis map, and valuation setup.FundamentalsDrivers, trajectory, and business quality.Financial reportsStatement tables, sorting, filtering, and acceleration.Ex-ante forecastTarget price, dividend yield, and total return by horizon.FactorsCompany factor exposure, rank, and universe context.Market viewMomentum, catalysts, charts, and symbol packet.AttributionLarge-move causes, residuals, and research backlog.OwnershipSEC 13F holder flow, crowding, and manager changes.PeersPeer heatmap and closest comparables.

Tab scope

Raw financial statements

Financial reports

Source and lookbackStored financial report rows12 report snapshots; latest report Jun 29, 6:38 AM GMT+8.

Sample and caveat28 reported metrics across 4 sections.Use this tab for its stated job; heavier model packets stay on their own tabs.

Traditional statement tables

Financial reports

12 reports · latest Jun 29, 6:38 AM GMT+8

Distinct report rows12

Sections4

Metrics28

Coverage100%

CompanyFUJIFILM Holdings Corp

Overview scoring

Fundamental overview

51/100 blended · 95/100 confidence · benchmark Closest peers

Blended fundamental score: Earnings 57/100; Cash flow 32/100; Balance sheet 46/100; Valuation 77/100.

Broad comparison

Cohort scorecard

Coverage-adjusted score with thinner cohorts automatically down-weighted

Cohort scorecard: Closest peers 51/100; Medical Specialties 64/100; Health Technology 52/100; JPJY constituent company universe 47/100.

Selected company rank

Rank and percentile

Confidence-adjusted standing inside each cohort

Rank and percentile: Closest peers #10 of 13; Medical Specialties #2 of 4; Health Technology #8 of 11; JPJY constituent company universe #116 of 168.

Section scoring matrix

Earnings, cash flow, balance sheet, and valuation

Heatmap score by cohort and statement section

Section scoring matrix: Closest peers Earnings 57/100; Cash flow 32/100; Balance sheet 46/100; Valuation 78/100.

Sort byFilter metrics

Specialist report review

Quant, PM, and risk-manager reads

Deterministic review lanes from stored report metrics

Quant review

Favorable acceleration7/21

Free cash flow has the largest second-order move at -124.65%. 7 metrics are accelerating favorably and 14 are decelerating.

Fundamental PM review

Growth and cash quality0/5

EPS TTM is 1.44 with -99.36% latest change. The PM lane checks revenue, EPS, cash flow, and margin confirmation together.

Risk manager review

Risk controls need review3 watch items

Current ratio is 1.37 with -4.71% latest change. The risk lane checks leverage, liquidity, and cash-yield deterioration.

Indexed report history

Financial report trend chart

First visible report = 100

Financial report trend chart: Total revenue 21.1B; Revenue quarter 5.8B; Revenue next quarter 4.9B; Operating income TTM 2.2B.

Second order change

Acceleration chart

Favorable acceleration means the latest move improved versus the prior move

Acceleration chart: Total revenue -100.73%; Revenue quarter -103.51%; Operating income TTM -100.03%; Operating margin -2.46%.

PM / risk lens

Risk and quality radar

Directional score from change and acceleration

Risk and quality radar: Growth 11/100; Cash 47/100; Quality 45/100; Balance 48/100; Valuation 34/100.

Earnings

Metric trend table

10 of 10 metrics shown

Metric	Latest	Change	Acceleration	Trend	Samples
Total revenueRevenue	21.1B	-99.36%-3.3T	-100.73%-3.3T	decelerating	11
Revenue quarterRevenue	5.8B	-99.32%-851.5B	-103.51%-886B	decelerating	11
Revenue next quarterRevenue	4.9B	-3.15%-159.5M	Need 3 reportsNeed 3 reports	deteriorating	2
Operating income TTMEarnings	2.2B	-99.38%-353.1B	-100.03%-355.4B	decelerating	11
Operating marginProfitability	+10.43%	-3.17%-0.34 pts	-2.46%-0.26 pts	decelerating	11
EPS TTMEarnings	1.44	-99.36%-224.60	-100.03%-226.11	decelerating	11
EPS next quarterEarnings	0.30	-11.96%-0.04	Need 3 reportsNeed 3 reports	deteriorating	2
Gross marginQuality	+40.80%	-8.32%-3.70 pts	-18.06%-7.65 pts	decelerating	12
Net marginQuality	+8.24%	-0.33%-0.03 pts	+0.32%+0.03 pts	stable	11
Gross-to-net conversionQuality	+20.20%	+9.07%+1.68 pts	+18.26%+3.55 pts	accelerating	12

Historical statement rows

Earnings report history

12 dated rows

Snapshot date	Total revenue	Revenue quarter	Revenue next quarter	Operating income TTM	Operating margin	EPS TTM	EPS next quarter	Gross margin	Net margin	Gross-to-net conversion
Oct 2, 2023	2.9T	727.7B	—	277.8B	+9.59%	197.37	—	+39.88%	+8.20%	+20.57%
Jan 4, 2024	2.9T	766.9B	—	275.4B	+9.43%	198.70	—	+40.10%	+8.19%	+20.44%
Apr 1, 2024	3T	805.5B	—	276.7B	+9.35%	202.04	—	+40.06%	+8.22%	+20.51%
Jul 1, 2024	3T	749B	—	286.7B	+9.40%	207.27	—	+40.39%	+8.19%	+20.27%
Oct 7, 2024	3.1T	765.7B	—	286.8B	+9.29%	199.25	—	+40.47%	+7.78%	+19.21%
Jan 6, 2025	3.1T	812.8B	—	295.1B	+9.42%	208.44	—	+40.45%	+8.02%	+19.82%
Apr 7, 2025	3.2T	868.3B	—	330.2B	+10.33%	216.36	—	+40.68%	+8.16%	+20.07%
Jul 7, 2025	3.2T	749.5B	—	343.3B	+10.74%	210.57	—	+40.80%	+7.94%	+19.47%
Oct 6, 2025	3.3T	822.9B	—	353B	+10.85%	224.53	—	+40.69%	+8.32%	+20.45%
Jan 5, 2026	3.3T	857.4B	—	355.3B	+10.77%	226.05	—	+40.54%	+8.27%	+20.39%
May 14, 2026	21.1B	5.8B	5.1B	2.2B	+10.43%	—	0.34	+44.50%	+8.24%	+18.52%
Jun 29, 2026	21.1B	5.8B	4.9B	2.2B	+10.43%	1.44	0.30	+40.80%	+8.24%	+20.20%